Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ju-Hsien Yao"'
Autor:
Ju-Hsien Yao, 姚如仙
96
The efficacy of arsenic trioxide(ATO, Trisenox®)against acute promyelocytic leukemia(APL)and relapsed acute promyelocytic leukemia has been well-documented. ATO has been approved by Food and Drug Administration(FDA)on September 2
The efficacy of arsenic trioxide(ATO, Trisenox®)against acute promyelocytic leukemia(APL)and relapsed acute promyelocytic leukemia has been well-documented. ATO has been approved by Food and Drug Administration(FDA)on September 2
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/07575917175648819821
Publikováno v:
Toxicology and Applied Pharmacology. 257:59-66
The efficacy of arsenic trioxide (ATO) against acute promyelocytic leukemia (APL) and relapsed APL has been well documented. ATO may cause DNA damage by generating reactive oxygen intermediates. Suberoylanilide hydroxamic acid (SAHA), a histone deace
Publikováno v:
Cancer Research. 71:2632-2632
The efficacy of arsenic trioxide (ATO) against acute promyelocytic leukemia (APL) and relapsed APL has been well-documented. ATO may cause DNA damage through the generation of reactive oxygen intermediates. Histone deacetylase inhibitor, suberoylanil